Is Wellgistics Health, Inc. Common Stock (WGRX) overvalued?
Wellgistics Health, Inc. Common Stock (WGRX) is a pharmaceutical retailers company listed on US.
This page asks whether Wellgistics Health, Inc. Common Stock (WGRX) looks expensive on cached numbers — not a short thesis.
No cached income statement for WGRX, so there is no earnings base to call rich or cheap.
WGRX currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next WGRX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the WGRX stock page for the full model, not this heading.
Not investment advice.